Latest filing published 19 Aug 2026 for Candel Therapeutics, Inc., €73k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Seshu Tyagarajan is a declared insider of Candel Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 16 filings, for trades running from 28 November 2022 to 17 August 2026.
On the open market, the record shows 2 purchases worth €24k and 9 sales worth €1.1M. Taken together, the sales exceed the purchases by €1.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 1 option exercise. 2026 to date brings no purchases and 2 sales.
Most recently, on 19 August 2026, the filings show an open-market sale worth €73k in Candel Therapeutics, Inc. The last insider purchase was made public on 12 December 2022, 1,411 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations